Norman Kneteman
President and CEO
Pharmaceuticals
KMT Hepatech Inc.
Canada
Biography
Dr. Norman Kneteman, MD, MSc, FRCSC, FACS, MS, is a Professor in the Department of Surgery at the University of Alberta and the Director of the Regional Clinical Programs in Transplantation and the Liver Transplant Program for Capital Health Authority. As the co-founder, President and CEO of KMT Hepatech, Inc., he carries overall responsibility for the conducted services and research. He held the CIHR (Canadian Institutes for Health Research) / Wyeth Chair in Transplantation Research. Dr. Kneteman received his Doctor of Medicine with Distinction and Master of Science in Experimental Surgery from the University of Alberta. Dr. Kneteman is a recipient of 40 Awards and Honors, author and co-author of 21 book chapters, 171 peer reviewed papers and 23 patents.
Research Interest
Business Development
